Stocks · News reference
Ping An Biomedical Co., Ltd. has entered into a letter of intent to acquire three tumor cell-related medical technology patents for a consideration of US$2 million to US$2.5 million.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Ping An Biomedical Co., Ltd. has signed a definitive agreement to acquire three tumor cell-related medical technology patents from Future Biotechnology Group Co., Limited for US$2.3 million.
Ping An Biomedical Co., Ltd. has received board approval for a 1-for-40 reverse stock split of its class A and class B ordinary shares.
Gainers Culp (NASDAQ:CULP) stock moved upwards by 17.5% to $4.1 during Wednesday's after-market session. The company's market cap stands at $43.3 million. As per the news, the Q1 earnings report came out today.
Shares of Pyxis Tankers Inc (NASDAQ:PXS) rose sharply in pre-market trading after the company reported better-than-expected earnings for the second quarter. The company posted quarterly earnings of 27 cents per
Gainers Bloomin Brands (NASDAQ:BLMN) stock moved upwards by 22.0% to $10.88 during Wednesday's pre-market session. The company's market cap stands at $763.6 million. The company's, Q2 earnings came out